Botulax 100unit: Essential Reconstitution and Handling Protocol for Professionals

Botulax 100unit is a botulinum toxin type A product originating from South Korea, manufactured by Hugel. It is presented as a lyophilized powder for solution, intended for professional use in aesthetic and therapeutic applications. As a key item in many professional inventories, understanding its specifications is crucial for clinics and resellers globally.

Professionals commonly source this presentation alongside other botulinum toxin products for a varied clinical offering. For larger volume needs, Botulax 200unit and Botulax 300unit are also available, providing flexibility for clinics managing different patient loads and treatment plans. This variety allows for efficient stock management and ensures consistent product availability.

Upon receipt, immediate inspection of Botulax 100unit packaging is necessary to confirm integrity and verify cold chain maintenance. The product must be stored at refrigerator temperatures between 2°C and 8°C. Any indication of temperature excursions or packaging damage should be noted immediately.

Maintaining the cold chain from the point of sourcing through to clinic storage is paramount. Each vial contains a precise amount of lyophilized powder, which requires specific conditions to preserve its integrity until reconstitution. Proper initial handling safeguards the product for its intended professional application.

Before reconstitution, gather all necessary sterile materials: a vial of Botulax 100unit, sterile 0.9% sodium chloride (non-preserved saline) for injection, an appropriate syringe (e.g., 1 mL), and a needle suitable for aspiration (e.g., 23-25 gauge).

Inspect the Botulax vial for any particulate matter or discoloration, though the lyophilized powder typically appears as a white, amorphous mass. Clean the rubber stopper of the vial with an antiseptic wipe before inserting the needle to maintain aseptic technique throughout the preparation process.

To reconstitute Botulax 100unit, draw the desired volume of sterile, non-preserved 0.9% sodium chloride into the syringe. The standard diluent is 0.9% sodium chloride without preservative, as preservatives can affect product stability.

Carefully insert the needle into the Botulax vial stopper. Slowly and gently inject the diluent into the vial, aiming for the side wall to minimize foaming and agitation of the lyophilized powder. Avoid vigorous shaking or agitation of the vial, as this can denature the botulinum toxin. Gently swirl the vial to ensure complete dissolution of the powder, which typically occurs rapidly without frothing.

The choice of diluent volume directly impacts the final concentration of the reconstituted solution. Professionals may select different dilution ratios based on their specific clinical applications and desired product concentration. The following table illustrates common dilution options for Botulax 100unit:

This table serves as a general reference for calculation; however, individual professional protocols may vary. When considering other neurotoxin options for your practice, refer to specific handling guides for products such as Nabota 100unit or explore the broader range within our Botulinum toxin / neurotoxin catalog.

Once reconstituted, Botulax 100unit should be stored under refrigerated conditions, typically between 2°C and 8°C. The stability of the reconstituted solution is generally established for up to 24 hours, though manufacturer guidelines may extend this period under specific conditions. Always adhere to the most current manufacturer recommendations.

Prior to drawing solution for use, gently invert the vial a few times to ensure uniform mixing. Avoid repeated aspiration and injection of air into the vial, which can compromise sterility and product integrity. Proper handling of the reconstituted vial minimizes waste and ensures consistent product quality for each professional application.

Following the professional use of Botulax 100unit, all used vials, syringes, and needles must be disposed of according to local and international biohazard waste regulations. Sharps should be placed in designated puncture-resistant containers.

Adhering to strict disposal protocols is a critical aspect of clinical practice, safeguarding both clinic personnel and the environment. Professionals bear the responsibility for ensuring all product-related waste is managed safely and compliantly, reinforcing best practices in an aesthetic clinical setting.